Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Excitotoxicity Markers After a Demyelinating Event (EXCEED)
NCT02523703Completed
- Sponsor
- CHU Caen Normandie
- Start
- Sep 2007
- Primary completion
- Feb 2012
01
Overview
Trial (2 arms), sponsored by CHU Caen Normandie. Primary endpoint: Glutamate concentration. Started Sep 2007; status: completed.
Beyond the preview
Go deeper on NCT02523703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02523703.